DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,386,433 | -11.5% | 29,772 | -14.4% | 0.27% | -9.7% |
Q2 2023 | $8,345,280 | -4.8% | 34,772 | 0.0% | 0.30% | -17.8% |
Q1 2023 | $8,763,935 | +10.1% | 34,772 | +15.9% | 0.36% | -56.2% |
Q4 2022 | $7,962,600 | +551.6% | 30,000 | +534.0% | 0.83% | +1337.9% |
Q3 2022 | $1,222,000 | +1.8% | 4,732 | 0.0% | 0.06% | +7.4% |
Q2 2022 | $1,200,000 | -11.7% | 4,732 | +2.2% | 0.05% | +8.0% |
Q1 2022 | $1,359,000 | -4.6% | 4,632 | +6.9% | 0.05% | 0.0% |
Q4 2021 | $1,425,000 | +4.7% | 4,332 | -3.1% | 0.05% | -5.7% |
Q3 2021 | $1,361,000 | +16.0% | 4,472 | +2.3% | 0.05% | +20.5% |
Q2 2021 | $1,173,000 | +21.9% | 4,372 | +2.3% | 0.04% | +33.3% |
Q1 2021 | $962,000 | -0.9% | 4,272 | -2.2% | 0.03% | -25.0% |
Q4 2020 | $971,000 | +5.2% | 4,369 | +1.9% | 0.04% | +15.8% |
Q3 2020 | $923,000 | +20.7% | 4,288 | -0.9% | 0.04% | -9.5% |
Q2 2020 | $765,000 | +22.6% | 4,328 | -4.0% | 0.04% | -6.7% |
Q1 2020 | $624,000 | -9.8% | 4,509 | 0.0% | 0.04% | +18.4% |
Q4 2019 | $692,000 | -3.2% | 4,509 | -9.0% | 0.04% | -9.5% |
Q3 2019 | $715,000 | +1.0% | 4,953 | 0.0% | 0.04% | +2.4% |
Q2 2019 | $708,000 | -83.0% | 4,953 | +800.5% | 0.04% | +156.2% |
Q1 2019 | $4,166,000 | +868.8% | 550 | -86.8% | 0.02% | -44.8% |
Q4 2018 | $430,000 | -15.2% | 4,166 | -10.7% | 0.03% | 0.0% |
Q3 2018 | $507,000 | +10.2% | 4,666 | 0.0% | 0.03% | 0.0% |
Q2 2018 | $460,000 | -47.6% | 4,666 | -48.0% | 0.03% | -50.0% |
Q1 2018 | $878,000 | +5.5% | 8,966 | 0.0% | 0.06% | +9.4% |
Q4 2017 | $832,000 | +0.4% | 8,966 | -7.2% | 0.05% | -5.4% |
Q3 2017 | $829,000 | +15.8% | 9,666 | +13.9% | 0.06% | +9.8% |
Q2 2017 | $716,000 | -1.1% | 8,485 | +0.2% | 0.05% | +2.0% |
Q1 2017 | $724,000 | -69.0% | 8,466 | -71.7% | 0.05% | -71.9% |
Q4 2016 | $2,333,000 | -0.7% | 29,966 | 0.0% | 0.18% | -9.2% |
Q3 2016 | $2,349,000 | -49.9% | 29,966 | -35.5% | 0.20% | -52.7% |
Q2 2016 | $4,693,000 | +3.3% | 46,466 | -2.9% | 0.41% | +0.7% |
Q1 2016 | $4,541,000 | +15.1% | 47,866 | +12.7% | 0.41% | +7.9% |
Q4 2015 | $3,944,000 | +9.0% | 42,466 | 0.0% | 0.38% | -4.3% |
Q3 2015 | $3,619,000 | -0.4% | 42,466 | 0.0% | 0.40% | +5.9% |
Q2 2015 | $3,635,000 | +0.8% | 42,466 | 0.0% | 0.38% | -3.3% |
Q1 2015 | $3,605,000 | -1.0% | 42,466 | 0.0% | 0.39% | -8.3% |
Q4 2014 | $3,640,000 | +12.8% | 42,466 | 0.0% | 0.42% | -2.3% |
Q3 2014 | $3,227,000 | -3.5% | 42,466 | 0.0% | 0.43% | -7.1% |
Q2 2014 | $3,343,000 | +5.0% | 42,466 | 0.0% | 0.47% | 0.0% |
Q1 2014 | $3,185,000 | -2.8% | 42,466 | 0.0% | 0.47% | -5.8% |
Q4 2013 | $3,278,000 | +11.3% | 42,466 | 0.0% | 0.50% | +0.6% |
Q3 2013 | $2,944,000 | +9.5% | 42,466 | 0.0% | 0.49% | +0.6% |
Q2 2013 | $2,688,000 | – | 42,466 | – | 0.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |